![Antoine Béret](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Antoine Béret is the founder of Trophos SA, which was founded in 1998.
He held the title of President & Head-Commercial Development from 2009 to 2012.
Dr. Béret is also the founder of Immunotech.
In addition to his founding positions, Dr. Béret held former positions as Chief Executive Officer at Genoscience Pharma, Chairman at Axenis SAS, Independent Director at Transgene SA, and Business Director at Crédit National SA.
Former positions of Antoine Béret
| Companies | Position | End |
|---|---|---|
Trophos SA
 Trophos SA Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention of neuronal loss for neurodegenerative diseases | Chief Executive Officer | 2009-11-09 |
Crédit National SA
 Crédit National SA Regional BanksFinance Provides banking services | Corporate Officer/Principal | - |
Immunotech
 Immunotech BiotechnologyHealth Technology Develops immunoassays and monoclonal antibodies | Founder | - |
Axenis SAS
 Axenis SAS BiotechnologyHealth Technology Develops gene technology and products | Chairman | - |
Genoscience Pharma
 Genoscience Pharma BiotechnologyHealth Technology Operates as a biotech company that develops unique small molecules in oncology | Chief Executive Officer | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
7
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Transgene SA
 Transgene SA BiotechnologyHealth Technology Designs and develops therapeutic vaccines and oncolytic viruses for the treatment of cancer | Health Technology |
Crédit National SA
Crédit National SA Regional BanksFinance Provides banking services | Finance |
Trophos SA
Trophos SA Pharmaceuticals: MajorHealth Technology Develops drugs for the prevention of neuronal loss for neurodegenerative diseases | Health Technology |
Immunotech
Immunotech BiotechnologyHealth Technology Develops immunoassays and monoclonal antibodies | Health Technology |
Genoscience Pharma
Genoscience Pharma BiotechnologyHealth Technology Operates as a biotech company that develops unique small molecules in oncology | Health Technology |
Axenis SAS
Axenis SAS BiotechnologyHealth Technology Develops gene technology and products | Health Technology |
- Stock Market
- Insiders
- Antoine Béret
